Can (18)F-FDG PET/CT predict EGFR status in patients with non-small cell lung cancer? A systematic review and meta-analysis

OBJECTIVES: This study aimed to explore the diagnostic significance of (18)F-fluorodeoxyglucose ((18)F-FDG) positron emission tomography (PET)/CT for predicting the presence of epidermal growth factor receptor (EGFR) mutations in patients with non-small cell lung cancer (NSCLC). DESIGN: A systematic...

Descripción completa

Detalles Bibliográficos
Autores principales: Du, Bulin, Wang, Shu, Cui, Yan, Liu, Guanghui, Li, Xuena, Li, Yaming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Diagnostics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190055/
https://www.ncbi.nlm.nih.gov/pubmed/34103313
http://dx.doi.org/10.1136/bmjopen-2020-044313

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8190055/
https://www.ncbi.nlm.nih.gov/pubmed/34103313
http://dx.doi.org/10.1136/bmjopen-2020-044313

Ejemplares similares